|
Real-time Estimate
Cboe BZX
12:28:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 75.69 USD | -0.66% |
|
-1.62% | +28.57% |
| 07-30 | Ingevity Corporation, Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Ingevity's Q2 Adjusted Earnings Increase, Net Sales Decline; 2026 Adjusted EPS Outlook Raised | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Diversified Chemicals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.62B | |||||
| 74.86B | |||||
| 50.95B | |||||
| 18.16B | |||||
| 14.66B | |||||
| 10.64B |
- Stock Market
- Stocks
- NGVT Stock
- Charts Ingevity Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
